Dr. Vukasin M. Jovanovic is a research fellow in the Stem Cell Translation Laboratory within the Division of Preclinical Innovation at the National Center for Advancing Translational Sciences (NCATS). He joined NCATS in May 2018 after completing his doctorate in physiology and cell biology at Ben-Gurion University of the Negev in Israel. Prior to this, he earned his master's degree in medical biochemistry from the University of Belgrade in Serbia. During his doctoral studies, Jovanovic's work was on elucidating the role of the BMP/SMAD pathway in orchestrating neurogenesis during the development of neural stem cells into midbrain dopaminergic neurons. At NCATS, Jovanovic's research focuses on harnessing multi-omics and single-cell technologies to develop diverse differentiation methods for efficiently generating human brain cell types from induced pluripotent stem cells (iPSCs). Through extensive cellular and molecular characterizations, he has established standard operating procedures for the robotic biomanufacturing of these human cell types, facilitating their use in drug screening and translational applications.
Dr. Vukasin M. Jovanovic is a research fellow in the Stem Cell Translation Laboratory within the Division of Preclinical Innovation at the National Center for Advancing Translational Sciences (NCATS). He joined NCATS in May 2018 after completing his doctorate in physiology and cell biology at Ben-Gurion University of the Negev in Israel. Prior to this, he earned his master's degree in medical biochemistry from the University of Belgrade in Serbia. During his doctoral studies, Jovanovic's work was on elucidating the role of the BMP/SMAD pathway in orchestrating neurogenesis during the development of neural stem cells into midbrain dopaminergic neurons. At NCATS, Jovanovic's research focuses on harnessing multi-omics and single-cell technologies to develop diverse differentiation methods for efficiently generating human brain cell types from induced pluripotent stem cells (iPSCs). Through extensive cellular and molecular characterizations, he has established standard operating procedures for the robotic biomanufacturing of these human cell types, facilitating their use in drug screening and translational applications.